Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma

被引：11
|
作者：
Cheng, Fajuan [1 ,2 ]
Zheng, Bin [3 ,4 ,5 ]
Wang, Jianwei [6 ]
Zhao, Guiting [4 ,5 ]
Yao, Zhongshun [4 ,5 ]
Niu, Zhihong [4 ,5 ]
He, Wei [4 ,5 ]
机构：
[1] Shandong Univ, Shandong Prov Hosp, Dept Nephrol, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Shandong Prov Hosp, Dept Nephrol, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Cheeloo Coll Med, Jinan, Shandong, Peoples R China
[4] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan, Shandong, Peoples R China
[5] Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan, Shandong, Peoples R China
[6] Shandong Univ, Shandong Prov ENT Hosp, Dept Urol, Jinan, Shandong, Peoples R China
来源：
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词：
histone deacetylase; overall survival; prognosis; renal cell carcinoma; signature; CANCER; EXPRESSION; APOPTOSIS; PROLIFERATION; DEGRADATION; EPIGENETICS; SUPPRESSION; INHIBITORS; MECHANISM; RELEVANCE;
D O I：
10.1002/cam4.4156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Histone deacetylases (HDAC) family is vital for tumorigenesis and tumor progression. However, the exact role of the HDAC family in clear cell renal cell carcinoma (ccRCC) remains unclear. Based on The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC), and The Human Protein Atlas (HPA) database, we investigated and validated the expression profile, clinical significance and prognostic value of HDAC family members in ccRCC. Moreover, we further explored the correlation between HDACs and tumor microenvironment, tumor stemness, drug activity and immune subtype. The HDAC8, HDAC10, and HDAC11 manifested potential clinical value for prognosis, and the correlation analyses reveals underlying molecular mechanisms, which deserve further investigation for ccRCC. This Integrated bioinformatics analysis, based on transcriptomics and proteomics, implied that HDAC8, HDAC10, and HDAC11 may serve as potential molecular biomarkers and therapeutic targets for ccRCC, but some underlying molecular mechanisms still need to be elucidated.
引用
收藏
页码：6503 / 6514
页数：12
相关论文
共 50 条
  • [31] An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
    Li, Jiaying
    Gui, Chengpeng
    Yao, Haohua
    Luo, Chenggong
    Song, Hongde
    Lin, Haishan
    Xu, Quanhui
    Chen, Xu
    Huang, Yong
    Luo, Junhang
    Chen, Wei
    FRONTIERS IN GENETICS, 2022, 13
  • [32] Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma
    Pan, Qiufeng
    Wang, Longwang
    Zhang, Hao
    Liang, Chaoqi
    Li, Bing
    MEDICAL SCIENCE MONITOR, 2019, 25 : 4401 - 4413
  • [33] A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
    Li, Zhiyuan
    Xia, Zhinan
    Yu, Yipeng
    Cai, Licheng
    Jian, Wengang
    Wang, Tengda
    Xue, Wei
    Wang, Xingyuan
    Wang, Bowen
    Zhang, Peng
    Yao, Wenhao
    Zhang, Cheng
    Wang, Chunyang
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [34] 4-miRNA Signature To Predict Clear Cell Renal Cell Carcinoma Metastasis and Prognosis.
    Wu, H.
    Wu, X.
    Weng, L.
    Li, X.
    Guo, C.
    Pal, S. K.
    Jin, J. M.
    Nelson, R. A.
    Mu, B.
    Onami, S. H.
    Wu, J. J.
    Ruel, N. H.
    Gao, H.
    Covarrubias, M.
    Figlin, R. A.
    Weiss, L. M.
    LABORATORY INVESTIGATION, 2011, 91 : 231A - 231A
  • [35] A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma
    Shi, Shanping
    Ye, Shazhou
    Wu, Xiaoyue
    Xu, Mingjun
    Zhuo, Renjie
    Liao, Qi
    Xi, Yang
    YONSEI MEDICAL JOURNAL, 2019, 60 (11) : 1013 - 1020
  • [36] 4-miRNA Signature To Predict Clear Cell Renal Cell Carcinoma Metastasis and Prognosis.
    Wu, H.
    Wu, X.
    Weng, L.
    Li, X.
    Guo, C.
    Pal, S. K.
    Jin, J. M.
    Nelson, R. A.
    Mu, B.
    Onami, S. H.
    Wu, J. J.
    Ruel, N. H.
    Gao, H.
    Covarrubias, M.
    Figlin, R. A.
    Weiss, L. M.
    MODERN PATHOLOGY, 2011, 24 : 231A - 231A
  • [37] An immune microenvironment related tumor microbiome signature to predict prognosis in clear cell renal cell carcinoma
    Xie, Y. Y.
    Luo, Z. W.
    Bi, X. G.
    EUROPEAN UROLOGY, 2022, 81 : S1643 - S1643
  • [38] A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma
    Meng, Wei
    Chen, Bo
    Jiang, Zhaosheng
    Cai, Bo
    Ma, Limin
    Guan, Yangbo
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (08) : 2071 - +
  • [39] PROGNOSTIC VALUE OF TISSUE BASED BIOMARKER SIGNATURE IN CLEAR CELL RENAL CELL CARCINOMA
    Haddad, Ahmed
    Luo, Jun-Hang
    Krabbe, Laura-Maria
    Darwish, Oussama
    Gayed, Bishoy
    Youssef, Ramy
    Kapur, Payal
    Rakheja, Dinesh
    Lotan, Yair
    Sagalowsky, Arthur
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1033 - E1033
  • [40] miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
    Ran, LongJiao
    Liang, Jian
    Deng, Xin
    Wu, JinYu
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
12345